Building the Gold Standard to Measure Muscle Wasting
The Future of Muscle Measurement
Revolutionizing Muscle Wasting Measurement
Obesity weight loss drugs will cause historic global muscle wasting for projected 150M people by 2030
Up to 40% of obesity drug weight loss can be muscle wasting loss.
Age-related muscle wasting (aka sarcopenia) is projected to grow to 200M people by 2050 due to global aging
Sarcopenia can lead to premature fall risk, the #1 cause of elderly injury death.
Current Muscle Wasting Meaures Fall Short
No gold standard and in-clinic only.
Myolex Electrical Impedance Myography (EIM)
We built the future gold standard to measure muscle wasting
Quantitative
Provides quantitative data on functional capability while the muscle and subject remain entirely at rest.
portable
Portable, non-invasive device that scans a single muscle in a matter of seconds.
Painless
EIM engages painless, active monitoring.
comprehensive
One holistic measure of both muscle composition and infrastructure.
Why EIM is a Superior Muscle Assessment
Comprehensive & Holistic
Measure Single Muscles Painlessly & at Home
Evidence Based Success. Myolex by the Numbers
*Requires FDA Approval.
**In mouse model research study, EIM identified ALS muscle deterioration very early at 8 weeks, four to six weeks earlier than other clinical standard muscle measures.
Myolex EIM. The First of Its Kind.
Available Today for Clinical Research
Let’s Discover Together.
